Arthroscopic Shoulder Surgery, Post Operative Pain, Acute
Conditions
Brief summary
Comparison between dexametidomedine\\bupivacaine and plain bupivacaine in superior trunk block for arthroscopic shoulder surgeries
Detailed description
This study will be conducted to investigate the efficacy of adding dexmedetomidine in STB for postoperative analgesia in patients undergoing arthroscopic shoulder surgery. * Inclusion Criteria: 1. age ;20-50 years old of both genders 2. American Society of Anesthesiologists physical status I and II 3. BMI less than 30 4. Arthroscopic shoulder surgeries. * Exclusion Criteria: 1. Patients with ASA more than II 2. Patients with a sepsis, malignancy anywhere 3. Patient with bleeding tendencies or on anticoagulation therapy 4. Patients with pre-existing neurologic deficit or neuropathy affecting brachial plexus 5. Allergy to study drugs. Study groups: The patients will be randomized into 2 groups: 1. Group DB: are administered Ultrasound guided STB with bupivacaine and dexametidomedine. 2. Group B: are administered Ultrasound guided STB with bupivacaine. Primary outcome: Duration of analgesia of Superior trunck block. Secondary outcome: 1. Cumulative dose of postoperative consumption of the rescue analgesia during 24h after STB 2. Durations of motor blockade (DOM) 3. Residual block related neurological symptoms 4. Hemodynamic variables 5. Dyspnea and sedation scale.
Interventions
DRUGdexametedomidine
1\. Group DB: are administered Ultrasound guided STB with bupivacaine and dexametidomedine.
DRUGBupivacain
2\. Group B: are administered Ultrasound guided STB with bupivacaine.
Sponsors
Ain Shams University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Age ;20-50 years old * Both genders * American Society of Anesthesiologists physical status I and II * BMI less than 30 * Arthroscopic shoulder surgeries.
Exclusion criteria
* Patients with ASA more than II * Patients with a sepsis, malignancy anywhere * Patient with bleeding tendencies or on anticoagulation therapy * Patients with pre-existing neurologic deficit or neuropathy affecting brachial plexus * Allergy to study drugs.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Duration of analgesia of Superior trunck block. | 24 hours | The DOA will be defined as the time interval between STB and the first need for the rescue analgesics. |
Countries
Egypt
Outcome results
None listed